1. Home
  2. GRFS vs SYM Comparison

GRFS vs SYM Comparison

Compare GRFS & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.71

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Symbotic Inc.

SYM

Symbotic Inc.

HOLD

Current Price

$54.34

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
SYM
Founded
1940
2005
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GRFS
SYM
Price
$8.71
$54.34
Analyst Decision
Hold
Hold
Analyst Count
2
14
Target Price
$10.15
$55.36
AVG Volume (30 Days)
608.0K
1.8M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
$2,246,922,000.00
Revenue This Year
$5.33
$24.66
Revenue Next Year
$6.50
$27.88
P/E Ratio
$18.67
$2,644.75
Revenue Growth
N/A
25.65
52 Week Low
$6.19
$16.32
52 Week High
$11.14
$87.88

Technical Indicators

Market Signals
Indicator
GRFS
SYM
Relative Strength Index (RSI) 39.04 44.18
Support Level $8.66 $48.60
Resistance Level $9.11 $63.57
Average True Range (ATR) 0.27 2.72
MACD -0.08 0.05
Stochastic Oscillator 27.18 44.42

Price Performance

Historical Comparison
GRFS
SYM

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

Share on Social Networks: